+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Rabies Vaccine Antibody Testing Service Market - Global Forecast 2025-2030- Product Image
Human Rabies Vaccine Antibody Testing Service Market - Global Forecast 2025-2030- Product Image
Sale

Human Rabies Vaccine Antibody Testing Service Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6141261
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Human rabies vaccine antibody testing services are critical for safeguarding at-risk populations and supporting public health initiatives, particularly as regulatory requirements and operational complexities intensify worldwide. This evolving market now demands advanced assay platforms, reliable quality assurance, and flexible service models to meet rising standards and global immunization goals.

Market Snapshot: Human Rabies Vaccine Antibody Testing Services

The human rabies vaccine antibody testing service market is experiencing steady growth, driven by increasing global efforts to eliminate rabies-related deaths and to ensure robust immune protection in both routine and high-risk scenarios. Key factors influencing the sector include the adoption of advanced serological and neutralization assays, shifting regulatory landscapes, and an expanding network of service providers and contract research organizations. The market demonstrates pronounced regional diversity, shaped by public-private partnerships, digital transformation, and operational modernization across clinical laboratories and healthcare systems.

Scope & Segmentation

  • Technique: Enzyme linked immunosorbent assay, fluorescent antibody virus neutralization test, rapid fluorescent focus inhibition test
  • End User: Blood banks, diagnostic laboratories, hospitals, research institutes
  • Test Type: Qualitative, quantitative
  • Sample Type: Plasma, serum, whole blood
  • Service Model: Inhouse, outsourced (contract research organizations, diagnostic service providers)
  • Region: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies: Eurofins Scientific SE, Laboratory Corporation of America Holdings, Charles River Laboratories International, Icon plc, IQVIA Holdings, Parexel International, WuXi AppTec, SGS SA, Q2 Solutions, PPD Inc.

Key Takeaways

  • Accelerated adoption of fluorescent antibody virus neutralization and high-throughput immunoassays has improved analytical reliability and testing efficiency across multiple settings.
  • Regulatory harmonization and advancing digital integration now enable standardized performance metrics, streamlined reporting, and improved quality management for rabies vaccine antibody testing services.
  • Clinical laboratories and research institutes increasingly balance inhouse testing with outsourced solutions from specialized contract research organizations to access technical expertise and scalable resources.
  • Service models are evolving to address operational challenges like supply chain disruption, especially following new tariff measures in key regions that increase procurement pressures.
  • Stakeholders benefit from collaborative networks, integrating public, private, and multinational resources to expand assay coverage, drive innovation, and enhance population-level monitoring.
  • The distinction between qualitative and quantitative assays enables efficient triage and informed clinical risk assessment, supporting both routine and outbreak response scenarios.

Tariff Impact on Value Chain

In 2025, new tariffs in the United States on imported reagents, assay kits, and consumables drove up operational costs and pressured existing supply chains. Laboratories responded by diversifying manufacturing sources, pursuing inhouse reagent production, and reformulating key assays to minimize reliance on tariff-affected materials. These changes introduced risks such as fluctuating lead times and temporary shortages, prompting providers to establish multi-tiered sourcing and collaborative mitigation strategies. The evolving tariff environment has necessitated greater operational agility and ongoing evaluation of procurement practices.

Methodology & Data Sources

This analysis utilizes a transparent methodology combining primary interviews with senior laboratory managers, contract research experts, and public health officials, alongside review of peer-reviewed journals, regulatory documents, and proprietary industry datasets. Data validation included triangulation and expert review to reconcile qualitative and quantitative trends for accuracy.

Why This Report Matters

  • Enables strategic decision-making by illuminating the interplay of technology evolution, regulatory compliance, and operational risk in the rabies vaccine antibody testing service market.
  • Supports the evaluation of new service models, supplier resiliency plans, and expansion opportunities across global and regional markets.
  • Delivers actionable insights into the impact of trade policies, digital transformation, and cross-sector collaborations for sustained organizational growth.

Conclusion

Senior leaders who leverage these market insights can proactively navigate operational, regulatory, and economic shifts. Integrating advanced testing technologies and robust supply chain strategies will support optimized health outcomes and enterprise sustainability in a dynamic global context.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing demand for rapid point-of-care rabies antibody testing in endemic regions driven by public health initiatives
5.2. Rising investments in high-throughput neutralizing antibody assay platforms to support vaccine effectiveness monitoring in global markets
5.3. Increased regulatory alignment and WHO prequalification processes accelerating market entry of novel rabies antibody test kits
5.4. Integration of digital reporting systems with antibody test workflows improving surveillance and data analytics for rabies control programs
5.5. Expansion of public-private partnerships funding affordable vaccine antibody monitoring services in low- and middle-income countries
5.6. Adoption of multiplex serological assays enabling simultaneous detection of rabies and other zoonotic disease antibodies in single test runs
5.7. Surge in demand for decentralized at-home rabies antibody self-testing kits in response to remote healthcare delivery trends
5.8. Research-driven development of next-generation biosensor-based rabies neutralization tests with enhanced sensitivity and lower turnaround times
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Human Rabies Vaccine Antibody Testing Service Market, by Technique
8.1. Introduction
8.2. Enzyme Linked Immunosorbent Assay
8.3. Fluorescent Antibody Virus Neutralization Test
8.4. Rapid Fluorescent Focus Inhibition Test
9. Human Rabies Vaccine Antibody Testing Service Market, by End User
9.1. Introduction
9.2. Blood Banks
9.3. Diagnostic Laboratories
9.4. Hospitals
9.5. Research Institutes
10. Human Rabies Vaccine Antibody Testing Service Market, by Test Type
10.1. Introduction
10.2. Qualitative
10.3. Quantitative
11. Human Rabies Vaccine Antibody Testing Service Market, by Sample Type
11.1. Introduction
11.2. Plasma
11.3. Serum
11.4. Whole Blood
12. Human Rabies Vaccine Antibody Testing Service Market, by Service Model
12.1. Introduction
12.2. Inhouse
12.3. Outsourced
12.3.1. Contract Research Organizations
12.3.2. Diagnostic Service Providers
13. Americas Human Rabies Vaccine Antibody Testing Service Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Human Rabies Vaccine Antibody Testing Service Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Human Rabies Vaccine Antibody Testing Service Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Eurofins Scientific SE
16.3.2. Laboratory Corporation of America Holdings
16.3.3. Charles River Laboratories International, Inc.
16.3.4. ICON plc
16.3.5. IQVIA Holdings Inc.
16.3.6. Parexel International Corporation
16.3.7. WuXi AppTec Co., Ltd.
16.3.8. SGS SA
16.3.9. Q2 Solutions LLC
16.3.10. PPD, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET: RESEARCHAI
FIGURE 26. HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET: RESEARCHSTATISTICS
FIGURE 27. HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET: RESEARCHCONTACTS
FIGURE 28. HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY RAPID FLUORESCENT FOCUS INHIBITION TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY RAPID FLUORESCENT FOCUS INHIBITION TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY BLOOD BANKS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY QUALITATIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY QUALITATIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY QUANTITATIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY QUANTITATIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY INHOUSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY INHOUSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY DIAGNOSTIC SERVICE PROVIDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY DIAGNOSTIC SERVICE PROVIDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 81. CANADA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 82. CANADA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 83. CANADA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. CANADA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. CANADA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 86. CANADA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 87. CANADA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 88. CANADA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 89. CANADA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 90. CANADA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 91. CANADA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2018-2024 (USD MILLION)
TABLE 92. CANADA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2025-2030 (USD MILLION)
TABLE 93. MEXICO HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 94. MEXICO HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 95. MEXICO HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. MEXICO HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. MEXICO HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 98. MEXICO HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 99. MEXICO HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 100. MEXICO HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 101. MEXICO HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 102. MEXICO HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 103. MEXICO HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2018-2024 (USD MILLION)
TABLE 104. MEXICO HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2025-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 144. UNITED KINGDOM HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2025-2030 (USD MILLION)
TABLE 155. GERMANY HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 156. GERMANY HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 157. GERMANY HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. GERMANY HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. GERMANY HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 160. GERMANY HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 161. GERMANY HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 162. GERMANY HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 163. GERMANY HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 164. GERMANY HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 165. GERMANY HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2018-2024 (USD MILLION)
TABLE 166. GERMANY HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2025-2030 (USD MILLION)
TABLE 167. FRANCE HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 168. FRANCE HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 169. FRANCE HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. FRANCE HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. FRANCE HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 172. FRANCE HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 173. FRANCE HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 174. FRANCE HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 175. FRANCE HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 176. FRANCE HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 177. FRANCE HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2018-2024 (USD MILLION)
TABLE 178. FRANCE HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2025-2030 (USD MILLION)
TABLE 179. RUSSIA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 180. RUSSIA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 181. RUSSIA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. RUSSIA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2025-2030 (USD MILLION)
TABLE 191. ITALY HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 192. ITALY HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 193. ITALY HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. ITALY HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. ITALY HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 196. ITALY HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 197. ITALY HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 198. ITALY HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 199. ITALY HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 200. ITALY HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 201. ITALY HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2018-2024 (USD MILLION)
TABLE 202. ITALY HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2025-2030 (USD MILLION)
TABLE 203. SPAIN HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 204. SPAIN HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 205. SPAIN HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. SPAIN HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. SPAIN HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 208. SPAIN HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 209. SPAIN HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 210. SPAIN HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 211. SPAIN HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 212. SPAIN HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 213. SPAIN HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2018-2024 (USD MILLION)
TABLE 214. SPAIN HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2025-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2025-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 228. SAUDI ARABIA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. SAUDI ARABIA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2025-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 240. SOUTH AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. SOUTH AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2025-2030 (USD MILLION)
TABLE 251. DENMARK HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 252. DENMARK HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 253. DENMARK HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. DENMARK HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. DENMARK HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 256. DENMARK HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 257. DENMARK HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 258. DENMARK HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 259. DENMARK HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 260. DENMARK HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 261. DENMARK HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2018-2024 (USD MILLION)
TABLE 262. DENMARK HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY OUTSOURCED, 2025-2030 (USD MILLION)
TABLE 263. NETHERLANDS HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 264. NETHERLANDS HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 265. NETHERLANDS HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. NETHERLANDS HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS HUMAN RABIES VACCINE ANTIBODY TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS HUMAN RABIES

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Human Rabies Vaccine Antibody Testing Service market report include:
  • Eurofins Scientific SE
  • Laboratory Corporation of America Holdings
  • Charles River Laboratories International, Inc.
  • ICON plc
  • IQVIA Holdings Inc.
  • Parexel International Corporation
  • WuXi AppTec Co., Ltd.
  • SGS SA
  • Q2 Solutions LLC
  • PPD, Inc.

Related Topics

Related Reports

Rabies Vaccine Antibody Testing Service Market - Global Forecast 2025-2030 - Product Image

Rabies Vaccine Antibody Testing Service Market - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Human Rabies Vaccines Market - Global Forecast 2025-2030 - Product Image

Human Rabies Vaccines Market - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Rabies Vaccine - Global Strategic Business Report - Product Image

Rabies Vaccine - Global Strategic Business Report

  • Report
  • 467 Pages
  • Global
From
Inactivated Polio and Rabies Vaccines Market Report 2025 - Product Image

Inactivated Polio and Rabies Vaccines Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Rabies Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Rabies Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.